tiprankstipranks
Advertisement
Advertisement
Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement
PremiumCompany AnnouncementsAutolus Therapeutics Signs Long-Term Lentiviral Supply Agreement
2M ago
Autolus Therapeutics price target lowered to $8 from $10 at Truist
Premium
The Fly
Autolus Therapeutics price target lowered to $8 from $10 at Truist
2M ago
Autolus: Short-Term Revenue Miss, Long-Term Blockbuster Potential Supports Buy Rating
Premium
Ratings
Autolus: Short-Term Revenue Miss, Long-Term Blockbuster Potential Supports Buy Rating
2M ago
Autolus Therapeutics sees FY26 AUCATZYL revenue $120M-$135M
PremiumThe FlyAutolus Therapeutics sees FY26 AUCATZYL revenue $120M-$135M
2M ago
Autolus Therapeutics sees cash runway into 4Q27
Premium
The Fly
Autolus Therapeutics sees cash runway into 4Q27
2M ago
Autolus Therapeutics to evaluate automated manufacturing of AUCATZYL
Premium
The Fly
Autolus Therapeutics to evaluate automated manufacturing of AUCATZYL
3M ago
Autolus Therapeutics appoints Ryan Richardson to board of directors
PremiumThe FlyAutolus Therapeutics appoints Ryan Richardson to board of directors
4M ago
Midday Fly By: Alphabet continues ascent, fueled by AI optimism
Premium
The Fly
Midday Fly By: Alphabet continues ascent, fueled by AI optimism
4M ago
Autolus Therapeutics announces NICE draft guidance recommending Aucatzyl
Premium
The Fly
Autolus Therapeutics announces NICE draft guidance recommending Aucatzyl
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100